Facilitators and barriers to adherence in the initiation phase of disease-modifying antirheumatic drug (DMARD) use in patients with arthritis who recently started their first DMARD treatment

2015

Journal of Rheumatology , Volume 42 - Issue 3 p. 379- 385

The Journal of Rheumatology Copyright

Additional Metadata
Keywords	Disease-modifying antirheumatic drugs, Medication adherence, Psoriatic arthritis, Qualitative research, Rheumatoid arthritis
Persistent URL	doi.org/10.3899/jrheum.140693, hdl.handle.net/1765/88363
Journal	Journal of Rheumatology
Rights	no subscription
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Pasma, A., van 't Spijker, A., Luime, J., Walter, M., van Busschbach, J., & Hazes, M. (2015). Facilitators and barriers to adherence in the initiation phase of disease-modifying antirheumatic drug (DMARD) use in patients with arthritis who recently started their first DMARD treatment. Journal of Rheumatology, 42(3), 379–385. doi:10.3899/jrheum.140693

Publication